chr16-3256323-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_000243.3(MEFV):c.265G>A(p.Ala89Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,698 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000243.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEFV | NM_000243.3 | c.265G>A | p.Ala89Thr | missense_variant | 1/10 | ENST00000219596.6 | NP_000234.1 | |
MEFV | NM_001198536.2 | c.265G>A | p.Ala89Thr | missense_variant | 1/9 | NP_001185465.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MEFV | ENST00000219596.6 | c.265G>A | p.Ala89Thr | missense_variant | 1/10 | 1 | NM_000243.3 | ENSP00000219596.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248292Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134686
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461468Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727026
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74364
ClinVar
Submissions by phenotype
Familial Mediterranean fever Uncertain:3Other:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 22, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 89 of the MEFV protein (p.Ala89Thr). This variant is present in population databases (rs104895124, gnomAD 0.007%). This missense change has been observed in individual(s) with familial Mediterranean fever (PMID: 14985395). ClinVar contains an entry for this variant (Variation ID: 97513). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on MEFV function (PMID: 14985395, 25006247). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided, no classification provided | literature only | Unité médicale des maladies autoinflammatoires, CHRU Montpellier | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Feb 08, 2023 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 02, 2022 | Variant summary: MEFV c.265G>A (p.Ala89Thr) results in a non-conservative amino acid change located in the DAPIN domain (IPR004020) of the encoded protein sequence which contains the "invariant approximately 90 amino acid N-terminal death-fold motif, the pyrin domain (PYD), that mediates cognate interactions with other proteins" (Masters et al 2009). Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 248292 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.265G>A has been reported in the literature in individuals affected with Familial Mediterranean Fever (example, Cazeneuve_2004, Dundar_2022). These report(s) do not provide unequivocal conclusions about association of the variant with Familial Mediterranean Fever. At least one publication reports experimental evidence evaluating an impact on protein function (example, Vajjhala_2014). These results showed no damaging effect of this variant based on structural, stability with studies demonstrating nearly identifical PYD (pyrin domain)/ASC (adaptor protein) interactions to wild-type pyrin protein. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Familial Mediterranean fever;C0085077:Acute febrile neutrophilic dermatosis;C1851347:Familial Mediterranean fever, autosomal dominant Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 03, 2021 | - - |
Acute febrile neutrophilic dermatosis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Feb 08, 2023 | - - |
Familial Mediterranean fever, autosomal dominant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Feb 08, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at